American National Registered Investment Advisor Inc. continued to hold its stake in shares of MetLife, Inc. (NYSE:MET) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,238 shares of the financial services provider’s stock at the end of the second quarter. American National Registered Investment Advisor Inc.’s holdings in MetLife were worth $837,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in MET. Atria Investments LLC raised its position in MetLife by 2.6% in the first quarter. Atria Investments LLC now owns 18,914 shares of the financial services provider’s stock valued at $999,000 after buying an additional 488 shares during the period. Prospera Financial Services Inc bought a new position in MetLife during the first quarter valued at $1,525,000. Tompkins Financial Corp raised its position in MetLife by 40.8% in the first quarter. Tompkins Financial Corp now owns 7,789 shares of the financial services provider’s stock worth $342,000 after buying an additional 2,258 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in MetLife by 3.5% in the fourth quarter. UBS Asset Management Americas Inc. now owns 4,148,498 shares of the financial services provider’s stock worth $223,563,000 after buying an additional 140,341 shares during the last quarter. Finally, Aberdeen Asset Management PLC UK raised its position in MetLife by 1.3% in the first quarter. Aberdeen Asset Management PLC UK now owns 469,645 shares of the financial services provider’s stock worth $24,807,000 after buying an additional 6,188 shares during the last quarter. 74.83% of the stock is currently owned by institutional investors and hedge funds.
MetLife, Inc. (MET) opened at 46.81 on Friday. The company has a market cap of $49.75 billion, a price-to-earnings ratio of 550.71 and a beta of 1.46. MetLife, Inc. has a one year low of $39.99 and a one year high of $51.77. The firm has a 50-day moving average price of $49.46 and a 200 day moving average price of $51.76.
MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business had revenue of $17.39 billion during the quarter, compared to the consensus estimate of $17.11 billion. During the same period in the previous year, the firm posted $0.83 earnings per share. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. Equities analysts expect that MetLife, Inc. will post $4.91 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 annualized dividend and a dividend yield of 3.42%. MetLife’s payout ratio is currently 1,777.98%.
WARNING: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2017/08/12/metlife-inc-nysemet-position-maintained-by-american-national-registered-investment-advisor-inc-updated-updated-updated.html.
MET has been the topic of a number of recent analyst reports. TheStreet lowered MetLife from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Royal Bank Of Canada restated a “buy” rating and issued a $62.00 price target on shares of MetLife in a research note on Wednesday, July 12th. Wells Fargo & Company restated a “buy” rating on shares of MetLife in a research note on Thursday, May 4th. Zacks Investment Research upgraded MetLife from a “sell” rating to a “hold” rating in a research note on Friday, May 5th. Finally, Argus cut their target price on MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, six have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. MetLife presently has an average rating of “Hold” and an average target price of $59.17.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.